InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,745.37
(
0.40%
)
US TECH 100
19,548.00
(
-0.16%
)
Dow Jones
42,175.11
(
0.62%
)
Brent Oil
71.32
(
0.51%
)
Bitcoin
65,825.18
(
0.99%
)
Post# of 144817
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

BioNewton

Send PM Follow Ignore
Followers 30
Posts 3271
Boards Moderated 0
Alias Born 05/06/2014

BioNewton

Re: None

Friday, 06/03/2016 9:30:47 PM

Friday, June 03, 2016 9:30:47 PM

Post# of 144817
PMCB - Clinical Trial Costs - Not as much as you think

The average cost per patient for a year for the treatment of Pancreatic Cancer is $20,000 for one year in a trial format. PMCB's trial is expected to last one year. There are supposed to be 84 patients. That comes to just under $1.7 Million. Anyone else worried about the costs associated with the trial? Me neither.

If you question that cost per patient feel free to check out the costs associated with Aduro Biotech's recent per patient costs.

PMCB has plenty of money to get this into clinical trials and also find their buyout partner. In fact they won't even need to touch that $50 Million but I'm sure that we look great to the value for the buying company.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent PMCB News
More PMCB News
InvestorsHub NewsWire

Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM

Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM

North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM

CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM

Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM

Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM

Start posting your company's news
Only $200 per official company press release!